Abstract
Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have